Amedisys (NASDAQ:AMED) Receives “Equal Weight” Rating from Stephens

Amedisys (NASDAQ:AMED)‘s stock had its “equal weight” rating restated by stock analysts at Stephens in a research note issued to investors on Wednesday,Benzinga reports. They presently have a $101.00 price objective on the health services provider’s stock. Stephens’ price target would suggest a potential upside of 8.97% from the stock’s current price.

Amedisys Trading Up 0.2 %

NASDAQ:AMED traded up $0.17 during mid-day trading on Wednesday, reaching $92.69. The company’s stock had a trading volume of 45,837 shares, compared to its average volume of 268,746. The stock has a market cap of $3.04 billion, a P/E ratio of 36.78, a P/E/G ratio of 1.82 and a beta of 0.73. Amedisys has a twelve month low of $82.15 and a twelve month high of $98.95. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. The company’s fifty day simple moving average is $89.66 and its two-hundred day simple moving average is $93.69.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the stock. Blue Trust Inc. lifted its position in Amedisys by 55.1% during the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider’s stock worth $34,000 after acquiring an additional 124 shares in the last quarter. HBW Advisory Services LLC acquired a new position in shares of Amedisys during the fourth quarter worth $38,000. Versant Capital Management Inc grew its holdings in Amedisys by 68.5% during the 4th quarter. Versant Capital Management Inc now owns 450 shares of the health services provider’s stock valued at $41,000 after purchasing an additional 183 shares in the last quarter. KBC Group NV purchased a new stake in Amedisys during the 3rd quarter worth $63,000. Finally, Vestcor Inc purchased a new position in Amedisys in the 4th quarter valued at about $73,000. Institutional investors and hedge funds own 94.36% of the company’s stock.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.